Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.

Oncology reports - 1 Aug 2005

Kuraoka Kazuya, Matsumura Shunji, Sanada Yuichi, Nakachi Kei, Imai Kazue, Eguchi Hidetaka, Matsusaki Keisuke, Oue Naohide, Nakayama Hirofumi, Yasui Wataru

Abstract excerpt

Death receptor 4 (DR4) is a member of the tumor necrosis factor-related apoptosis-inducing ligand receptor genes. A single nucleotide polymorphism (Thr or Arg, C or G) in the extracellular domain was reported to be associated with a risk of lung cancer, head and neck cancer, and bladder cancer. In this study, we examined the association between the DR4 polymorphism and gastric cancer. The Thr/Thr, Thr/Arg and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Receptors, TNF-Related Apoptosis-Inducing Ligand

Share to Receptors, Tumor Necrosis Factor

Share to Stomach Neoplasms

Source

Identifiers

PMID: 16012731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.PMID 16012731Read ↗

Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis.Semantic proximity Read ↗

Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.Semantic proximity Read ↗

Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.Semantic proximity Read ↗

Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population.Semantic proximity Read ↗

Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.Semantic proximity Read ↗

Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.Semantic proximity Read ↗

Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.Semantic proximity Read ↗

TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis.Semantic proximity Read ↗

Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China.Semantic proximity Read ↗

Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer.Semantic proximity Read ↗

Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.Semantic proximity Read ↗

Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.